Skip to main content Back to Top

From the Frontline of COVID-19: Clinician Perspectives on Anticoagulation

Broadcast Date: May 15, 2020


Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

We chat with Michael Gulseth about the unique aspects of treating COVID-19 patients that present with coagulopathies. Assessing risk of thromboembolism and anticoagulation strategies in these patients will also be discussed.


Michael GulsethMichael P. Gulseth, Pharm.D., BCPS, FASHP, is the Program Director for Anticoagulation Services at Sanford USD Medical Center in Sioux Falls, SD. He is also a Clinical Associate Professor, Department of Internal Medicine, at the University of South Dakota Sanford School of Medicine. Dr. Gulseth received his Doctor of Pharmacy degree in 1999 from North Dakota State University in Fargo, North Dakota. He completed residency training at United Hospital in St. Paul, Minnesota.

Dr. Gulseth is author and editor of Managing Anticoagulation Patients in the Hospital: the Inpatient Anticoagulation Service, published in 2007 by the American Society of Health-System Pharmacists (ASHP). He is a co-editor and author of Anticoagulation Therapy: A Clinical Practice Guide, 2nd edition published in 2018, by the ASHP.

Dr. Gulseth is an active member of several professional pharmacy organizations, including the ASHP, the Minnesota Society of Health-System Pharmacists (MSHP), the South Dakota Society of Health-System Pharmacists, and the American College of Clinical Pharmacy. He has served on the Editorial Advisory Board of the American Journal of Health-System Pharmacy and is a past president of MSHP. He was elected a Fellow of the ASHP in 2011 and a fellow of MSHP in 2020. His research interests include evaluation of antithrombotic therapy safety and efficacy and evaluation of the benefits of pharmacist-managed anticoagulation services. He is the President and owner of Michael P Gulseth Anticoagulation Consulting, Inc.

Vicki BasalygaVicki Basalyga, Pharm.D., BCPS, BCPPS, is the Director for the Section of Clinical Specialists and Scientists. In this role Vicki serves as an information resource and provides guidance to ASHP members regarding science and scientific developments affecting pharmacy practice in health systems. She serves as secretary to the Section executive committee and coordinates activities to accomplish the objectives established by the Section. Additionally, Vicki has assumed the position of Council Secretary for the ASHP's Council on Therapeutics.

Vicki received her Doctor of Pharmacy from Duquesne University and completed an ASHP accredited PGY1 at Children’s National Medical Center in Washington, DC. Vicki is also a Board Certified Pharmacotherapy Specialist and a Board Certified Pediatric Pharmacotherapy Specialist.

Prior to her current position at ASHP, Vicki practiced as critical care pharmacist in both the Cardiac Intensive Care Unit and the Pediatric Intensive Care Unit at Children’s National Medical Center in Washington, DC. Other activities Vicki performed included drafting policies and procedures, co-chairing the Antimicrobial Stewardship Program, creating and drafting order sets for CPOE conversion and precepting residents and students.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.